Osel, Inc.: Clinical Trials

5 trials sponsored by Osel, Inc., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 not yet recruiting, 1 withdrawn. 5 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 25Completed 3, Not yet recruiting 1, Withdrawn 1

Follow Osel, Inc.: new trials by email

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase II Trial of Pembrolizumab/Chemotherapy With Live Biotherapeutic Product MO-03 in Patients With Early Stage Triple Negative Breast Cancer
Live biotherapeutic product: MO-03 1 capsule PO BID - TNBC - Triple-Negative Breast Cancer, TNBC
Phase 2Not yet recruitingYuan Yuan502026-09-012026-08-05
Phase 2 Trial of LACTIN-V in Women at High Risk of HIV Acquisition
LACTIN-V, Placebo - Bacterial Vaginosis, HIV Infections
Phase 2CompletedUniversity of California, San Francisco452021-05-102024-08-13
Safety and Clinical Effectiveness of Oral Probiotic MIYA-BM to Prevent Recurrent Clostridium Difficile Infections
MIYA-BM Fine Granules (CBM588), Placebo Fine Granules (without CBM588) - Clostridium Difficile Infection
Phase 2WithdrawnOsel, Inc.2010-02-012013-11-11
Safety and Efficacy Study of Lactobacillus Administered Vaginally in Women With Bacterial Vaginosis
LACTIN-V, Placebo control substance - Bacterial Vaginosis
Phase 2CompletedOsel, Inc.402008-04-012009-07-10
Intravaginal LACTIN-V for Prevention of Recurrent Urinary Tract Infection
Lactin-V, Placebo - Urinary Tract Infection
Phase 2CompletedUniversity of Washington1002006-03-012023-04-14

Conditions studied

Vaginosis, Bacterial (2)  ·  Bacterial Infections (1)  ·  Clostridium Infections (1)  ·  Colitis (1)  ·  Colonic Diseases (1)  ·  Cystitis (1)  ·  Diarrhea (1)  ·  Digestive System Diseases (1)  ·  Enterocolitis (1)  ·  Enterocolitis, Pseudomembranous (1)  ·  Gastroenteritis (1)  ·  Gastrointestinal Diseases (1)  ·  Gram-Positive Bacterial Infections (1)  ·  HIV Infections (1)  ·  Intestinal Diseases (1)

Countries

United States (3)  ·  South Africa (1)

Top investigators

Anke Hemmerling, MD, MPH, PhD (1)  ·  Ann E Stapleton, MD (1)  ·  Craig R Cohen, MD MPH (1)  ·  Craig R Cohen, MD, MPH (1)  ·  Jin Sun Lee-Bitar, MD (1)  ·  Lynne V. McFarland, Ph.D. (1)  ·  Yuan Yuan, MD (1)

Results publications

PMID 20644497, PMID 21498386, PMID 21992977, PMID 40194532, PMID 40206350

NIH funding

P01DK053369 (1), R01HD098978 (1)